Go to the profile of Synaffix

Synaffix

 
Contact

About Synaffix

Synaffix enables ADCs for oncology that are both safer and more effective as well as easier to manufacture.

Therapeutic Areas

Oncology

Technologies

Antimicrobial

Company Type

Biotechnology – Therapeutics

State of Ownership

Other

Influencer Of

Go to the profile of Ertyery Hhggh

Ertyery Hhggh

Go to the profile of Najoua Borkadi

Najoua Borkadi

Business Development Associate Director, University of Michigan

Go to the profile of Microquin

Microquin

Go to the profile of Jillian Adie

Jillian Adie

Publishing Manager, Nature

Go to the profile of Albany A. Cordova Martins

Albany A. Cordova Martins

Business Development Executive, Nature Publishing Group, Springer Nature

Go to the profile of Carmen Ramirez

Carmen Ramirez

Sales Account Executive, Springer Nature

Go to the profile of Jenefer Thoroughgood

Jenefer Thoroughgood

Managing Director, Thoroughly Good Consulting

Go to the profile of Claire Thompson

Claire Thompson

Global Manager, Business Development, Nature Publishing Group

Go to the profile of Charles Thiede

Charles Thiede

CEO & Co-Founder, Zapnito

Popular Contributions

Topics

Topics contributed to:

Drug Development

Editions participated in:

March 2016

Online Elsewhere

Experts Like Synaffix

Go to the profile of LifT Biosciences

LifT Biosciences

Go to the profile of Korea Drug Development Fund

Korea Drug Development Fund

Go to the profile of Brightpath Biotherapeutics

Brightpath Biotherapeutics

Go to the profile of PDC*line Pharma

PDC*line Pharma

Go to the profile of Oncopeptides

Oncopeptides

Content From Similar Experts